Dr Steven Rowe shares insights into the prostate cancer imaging landscape and the logistics involved with different radiotracers, with particular emphasis on PYLARIFY® (piflufolastat F 18).
Video Library —February 15, 2022
Categories:
Interview with the InnovatorsLast modified: November 15, 2022